4D Molecular Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsSep 28 →InsidersNo open-market buys. 3 insiders sold $1.5M, 8 of 12 sales on a 10b5-1 plan.→HoldersJupiter Topco 10.4%Ra 9.1%BlackRock 8.2%→Financing →PeersClosest companies: TYRA, PMVP, ALEC→
From the filings
Figures
- Revenue
- $92.0Mlast 12 months
- Net income
- −$179.2Mlast 12 months
- Operating cash flow
- −$129.4Mlast 12 months
- Cash and equivalents
- $70.4Mat the last balance sheet
- Total debt
- $19.6Mat the last balance sheet
- Shares outstanding
- 55.2M shareson issue